D&O cover gap review in the Netherlands: scope and consequences

A D&O cover gap review in the Netherlands tests whether the liability insurance a Dutch board carries actually responds to the exposure Dutch company law creates for its directors, and identifies where it does not. There is no statutory requirement to hold directors' and officers' insurance in the Netherlands, which is exactly why the gap so rarely surfaces before a claim tests it. The review sets the personal liability regime under Dutch company law against the wording of the policy, the entities the policy actually names, and the board decisions that trigger its exclusions.

A Dutch private company (BV) with a foreign parent replaces its finance director mid-year. Three weeks later the new director signs off on a shareholder loan restructuring without checking whether the group's D&O policy still names the entity correctly after the change of control. A creditor challenges the transaction eighteen months later. By then the policy period in which the claim should have been notified has already closed.

This page sets out what the Dutch requirement actually tests, where the gap becomes visible on a filing or a register entry, and where the advisory work on it stops.

What changes in the Netherlands for a D&O cover gap review

The mechanics of a D&O cover gap review are the same in every jurisdiction this practice covers: map the liability a director actually carries, then test the wording of the policy against that map, item by item. What changes in the Netherlands is the shape of the liability being mapped. Dutch company law attaches personal exposure to directors through a route that many standard D&O policies were never drafted to answer, and a review that treats the Netherlands as a generic EU jurisdiction will miss it.

Dutch company law also requires every BV and NV to maintain a registered office in the Netherlands, recorded at the Chamber of Commerce, and this affects where a claim against a director is properly brought and where the paper trail behind a board decision needs to sit. A review that examines only the insurance contract, without checking where that record lives, is an incomplete review.

For the underlying eligibility and residence rules that determine who can sit on a Dutch board in the first place, see the jurisdiction brief on director eligibility in the Netherlands; a cover gap review assumes that question is already settled and starts from the exposure the sitting board actually carries.

The local requirement that drives a D&O cover gap review in the Netherlands

There is no statutory requirement to carry directors' and officers' insurance in the Netherlands. Dutch annual accounts legislation does not require a company to disclose whether such cover is held or on what terms, and the position is a matter for the board to record internally rather than file publicly. 01 That absence of a filing obligation is precisely why the gap review matters: nothing forces the question onto the board's agenda, so it only surfaces once a claim is already in front of the company.

What Dutch law does impose is a personal liability standard the review has to test the policy against, and this sits at the centre of directors' duties and personal liability work generally. Under Book 2 of the Dutch Civil Code, a director can be held jointly and severally liable for the company's obligations where the board's conduct amounts to manifestly improper performance of its management duties, a standard applied most often once a company is insolvent. 02 The test does not turn on one act; it looks at the pattern of decisions the board made and whether a reasonably competent director, facing the same facts, would have acted differently. A D&O policy drafted around a narrower, act-specific trigger can leave exactly this pattern-based exposure uncovered.

The same open-textured character explains why comparing cover across borders is unsafe without doing the work locally. The equivalent review for a Singapore board tests a more codified duty of care, and the comparison between the Singapore and DIFC liability standards shows how differently two common-law regimes frame the same underlying question. The Dutch civil-law test sits differently again. A group running one global D&O programme across several boards should treat each jurisdiction's test as a separate question, not a variation on the same theme.

The consequence of leaving this untested is specific, not general: once a claim is notified to the insurer outside the period the policy actually covers, the right to indemnity under that policy ceases to be available, and no gap review carried out afterwards can restore it.

A director carrying this exposure without a tested policy is relying on cover that may not answer the claim that actually arises. Confirming that before a claim is filed, not after, is the point of doing this now.

Assess your director exposure. Write to info@hreithlaw.com with the jurisdiction and the structure.

The filing and register consequence in the Netherlands

A D&O cover gap review does not itself generate a filing, but two of the steps that typically follow one do, and both are worth flagging before the board commits to either.

Every Dutch BV and NV must maintain a registered office in the Netherlands, recorded at the Trade Register held by the Chamber of Commerce, and this is the address against which formal notices, including notification of a potential claim, are treated as validly served. 03 If the review recommends adding or tightening an indemnification clause in the company's articles of association, that amendment requires a notarial deed and a shareholders' resolution passed by the majority the articles themselves set, under Book 2 of the Dutch Civil Code. 04 A resolution recorded only in a board minute is not a substitute for that deed, and treating it as one is the most common way a review's recommendation fails to actually take effect.

Separately, the Netherlands maintains a register of beneficial owner data at the Chamber of Commerce, and a defined set of that beneficial owner information is publicly accessible unless a shielding request is granted on specific, narrow grounds set out in the applicable regulation. 05 A cover gap review does not change what sits on that register, but a board restructuring prompted by the review, such as replacing a director whose personal exposure has become disproportionate, will itself generate an entry on it. Neither event is, by itself, a regulatory filing in the sense of notifying a supervisor; both are simply entries recorded on a public register maintained by the Chamber of Commerce. The separate note on the board resolutions a cover gap review typically requires sets out that documentation trail in full, including which resolutions need to be filed and which stay internal.

The sequencing matters more than the drafting. A resignation filed at the Chamber of Commerce without a board resolution addressing the departing director's cover position becomes visible on the register the same day it is filed, and the window to record the board's position before that filing closes off once the deed of resignation is executed.

Before the board signs off on any of the above, four items should already be on the table:

• The current D&O policy schedule, including named entities and territorial scope.
• The board minute or resolution addressing the specific exposure the review identified.
• Confirmation of the registered office and Trade Register entry currently on file.
• Any pending beneficial owner register update triggered by a change on the board.

What this service does not include in the Netherlands

A D&O cover gap review maps the requirement, tests the policy against it, and sets out the exposure that remains once that comparison is done. It does not include acting as a director, secretary or nominee shareholder for the company under review, and it does not include sourcing, supplying or arranging for another person to take on any of those roles. Providing director services for a third party as a business activity in the Netherlands is a licensed activity under the Trust Offices Supervision Act, supervised by the Dutch Central Bank, and arranging for someone else to provide that service is treated the same way. 06 That is a licensing boundary, not a preference: the firm does not hold that licence and does not operate as though it does. This is where the boundary of directors' duties and personal liability work meets the boundary of licensed activity, and the two are kept deliberately separate.

What the client receives instead is the analysis a licensed provider, an insurer, or the board itself then acts on: the exposure mapped against the actual policy wording, the gap stated in terms a broker can price, and the board resolutions needed to record the decision, drafted for the board to adopt in its own name. Where the review points toward replacing a director or restructuring how the board is composed, the appointment terms and the person filling the role remain matters for the company and, where relevant, a licensed trust office to arrange, not for this engagement.

• No acting as, or supplying, a director, secretary, nominee shareholder or trustee.
• No arranging for a third party to take on any of those roles.
• No activity requiring a Dutch trust office licence.

Where the review points to a board change, the appointment terms need reviewing before the resignation or appointment is filed, not after the register already shows it. That is a narrower question than the full review, and one the board can act on quickly.

Assess your director exposure. Write to info@hreithlaw.com with the jurisdiction and the structure.

Frequently asked questions

Does the review change for a company with a foreign parent?

The test under Dutch company law on director liability is the same regardless of who owns the shares, but a foreign parent usually means a group-wide D&O programme drafted under a different legal system, and that policy's wording rarely anticipates the Dutch improper-management standard. The review has to check the master policy against the Dutch test specifically, rather than assume the group's home-jurisdiction cover translates without adjustment.

What does the review require in practice, and in what order?

It starts with the exposure, not the policy: mapping which decisions and which office holders carry personal risk under Dutch company law. Only once that map exists does comparing it against the policy schedule and its exclusions produce a usable answer, rather than a list of clauses with no reference point to test them against.

Who inside the company is responsible for commissioning it?

Assuming this sits with the insurance broker or the finance function alone is the wrong starting point; the exposure being tested is personal to each director, so the board as a body has to own the decision to run the review, even where the paperwork is delegated. Treating D&O cover as a formality signed off once a year is the most common reason a gap goes unnoticed until a claim tests it.

What evidence should the board keep once the review is done?

A dated board minute recording the exposure identified and the decision taken on it, the policy schedule current at that date, and, where the articles were amended, the notarial deed giving effect to the change. Evidence created after a claim has already arisen carries far less weight than a contemporaneous record made before one existed.

What happens if the gap is not addressed?

Nothing happens on the register or in a filing; the gap simply stays invisible until a claim is made, at which point the director facing personal liability discovers whether the policy responds at the moment it matters most, not before. By then the option to restructure cover ahead of the event that caused the claim no longer exists.

Julia Anholt, expert author at Halvorsen & Reith, focuses on director liability, board governance and cross-border D&O coverage questions for group structures with a Dutch entity in the chain. She advises on how liability standards under Dutch company law interact with insurance drafted under other legal systems, and on the board documentation that supports both. Her work sits alongside the firm's wider director duties practice rather than any insurance placement function.